Radiology Equipment Purchase Analyzer
A real-options approach to imaging capital decisions — when uncertainty meets the option to wait.
Why Real Options Beats NPV for Imaging Capital Decisions
Start HereNet Present Value (NPV) and Internal Rate of Return (IRR) assume you must commit today or never. But imaging capital decisions rarely work that way. You can wait six months, watch a payer decision, see what a competitor does, or negotiate a better price on next year’s model.
Real options analysis values the option to wait when (1) the decision involves significant uncertainty, (2) the investment is largely irreversible, and (3) you have flexibility in timing. For a $2–3 million MRI or PET/CT decision, all three conditions usually hold.
This tool implements the McDonald-Siegel investment trigger model. It tells you the present value of cash flows above which you should invest now, and how close your current expected cash flows are to that trigger.
Three Numbers That Drive the Decision
Investment Elasticity
The math output that translates uncertainty into a required premium. Higher volatility raises β, which pushes the investment trigger farther above the equipment cost. You don’t set β — it’s solved from r, σ, and δ.
Investment Trigger
The minimum present value of future cash flows that justifies investing now rather than waiting. Always larger than the capital cost K. The premium S* − K is the value of keeping your option open.
Readiness Ratio
S₀ divided by S*. The single number that drives the recommendation. Below 0.7 says wait. Between 0.7 and 1.0 says monitor and negotiate. At or above 1.0 says invest now — you’ve cleared the bar.
When to Use This Tool
Best Fit- 3T MRI replacement or addition with uncertain volume ramp.
- PET/CT or PET/MRI service-line launch where reimbursement evolves.
- Second outpatient imaging site with site-of-service competition.
- AI workflow platforms where pricing and clinical utility are still settling.
- Photon-counting CT, theranostics, or other emerging modalities with deferral value.
- Capacity expansion when current utilization signal is noisy.
When NOT to Use This Tool
Wrong Fit- End-of-life regulatory replacements where you have no real option to defer.
- Low-uncertainty refresh cycles on commodity ultrasound or radiography units.
- Decisions driven by safety mandates (ACR Zone retrofits, JC findings) where deferral isn’t acceptable.
- Sub-$500K equipment where the option premium is small relative to evaluation effort.
- Decisions that have already been committed in budget or board approval.
The Core Insight
Plain EnglishIf the future is uncertain and you can wait, waiting has value. A standard NPV calculation ignores this and will tell you to invest as soon as expected cash flows exceed the equipment cost. Real options analysis tells you to require a premium — a margin of safety that grows with uncertainty.
For radiology, that premium is real money. At σ = 30% volatility, a 5% risk-free rate, and an 8% cost of waiting, the trigger sits roughly 1.5× above the equipment cost. A $2.5M MRI doesn’t justify investment at $2.5M of expected discounted cash flows — it justifies investment at roughly $3.75M.
If you’re not clearing that bar, the right answer is often to wait, renegotiate, or restructure the deal — not to invest.
1. Equipment & Financial Inputs
Required2. Build Present Value from Procedures
OptionalEstimate S₀ from expected procedure volumes, growth rates, and margins. Or check “Use S₀ override” above to skip this section and enter a value directly.
| Procedure / CPT Label | Base Annual Volume | Annual Growth % | Margin per Exam (USD) |
|---|
3. What-If Sliders
Quick ScenariosDrag to explore how your answer moves under different assumptions. Click Apply to push these values into the form above.
4. Decision & Results
OutputReadiness Gauge
Annual Cash Flow Projection
Procedure Revenue Mix (Year 1)
Trigger vs. Uncertainty
Worked Example: 3T MRI Replacement at a Mid-Size Hospital
Step-by-StepA 250-bed regional hospital is considering replacing its aging 1.5T MRI with a Siemens MAGNETOM Vida 3T system. Volume has been steady but neurology and orthopedic surgery want stronger imaging to retain referrals. Reimbursement is stable but Medicare site-of-service differentials are unsettled. The capital request is $2.5M including installation and magnet swap.
Step 1 — Set the Financial Frame
| Parameter | Value | Rationale |
|---|---|---|
| Capital cost, K | $2,500,000 | Equipment, install, siting, validation, project management. |
| Risk-free rate, r | 4.3% | 10-year U.S. Treasury at evaluation date. |
| Uncertainty, σ | 30% | CoV of last three years of MRI service-line contribution margin. |
| Cost of waiting, δ | 8% | Estimated reimbursement erosion + share loss to a competitor 4 miles away. |
| Decision window, T | 2 years | Vendor pricing valid 18 months; current MRI good for 24 months. |
| PV horizon, H | 10 years | Expected useful life of the 3T system. |
| Annual Opex | $350,000 | Service contract + 0.5 incremental tech FTE + helium + supplies. |
Step 2 — Build the Procedure Mix
The MRI service line is built from four procedure families with hospital-outpatient global contribution margins:
| Procedure | Base Annual Volume | Growth % | Margin / Exam | Year-1 Revenue |
|---|---|---|---|---|
| MRI Brain w/wo contrast | 740 | 3% | $420 | $310,800 |
| MRI MSK (knee, shoulder, lumbar) | 1,800 | 4% | $380 | $684,000 |
| MRI Abdomen / Pelvis | 600 | 2% | $510 | $306,000 |
| MRI Cardiac / Vascular | 180 | 6% | $680 | $122,400 |
| Year-1 Gross Margin | $1,423,200 | |||
Step 3 — Compute the Decision Numbers
The procedure-built PV ($10.42M) is well above the trigger ($4.50M), giving ρ = 2.31. This decisively clears the bar.
Step 4 — Stress Test the Decision
Before committing, test how robust this is to your most fragile assumptions:
| Stress Test | What Changes | New ρ | Decision Holds? |
|---|---|---|---|
| Volume forecast is 30% optimistic | All base volumes × 0.70 | 1.43 | Yes (Invest) |
| Margins compress 20% from payer mix shift | All margins × 0.80 | 1.73 | Yes (Invest) |
| Both shocks happen together | Volume × 0.70 and margin × 0.80 | 1.02 | Yes (Invest, just barely) |
| Severe payer disruption (HOPD site-neutral) | Margins × 0.50 | 0.85 | No — drops into Monitor band |
The decision is robust to ordinary forecast error and survives a combined volume + margin shock with ρ barely above 1.0. A severe site-neutral payment shock, however, pushes the analysis into the Monitor band — renegotiate price or secure payer clarity before signing.
Step 5 — A Contrasting Case
The same hospital is also considering a $1.8M PET/CT to launch a new service line. There’s no current PET volume, so the volume forecast carries far more uncertainty (σ = 0.45). Cost of waiting is lower (δ = 0.04) because no competitor is in the market.
This is the value of the framework. Two decisions that look superficially similar — both NPV-positive — have opposite recommendations because their uncertainty profiles differ.
Sensitivity Lab
Which Inputs Matter MostThe same model can produce very different recommendations depending on which input you got wrong. This tab shows how the readiness ratio ρ responds when each input is shocked ±20% from the values you’ve entered in the Calculator tab. Read it as a triage list: longer bars are the assumptions you most need to defend.
Update the inputs in the Calculator tab and the charts here will refresh.
Tornado Chart — Impact on ρ from ±20% Shocks
Triage ToolS* as σ Varies
Uncertainty → TriggerComparative static: Higher σ raises S*. More uncertainty means a larger required premium. Doubling volatility can roughly double the trigger.
S* as δ Varies
Cost of Waiting → TriggerComparative static: Higher δ lowers S*. When waiting is expensive (competitor entry, reimbursement erosion), the bar to invest drops.
S* as r Varies
Risk-Free Rate → TriggerComparative static: Higher r generally raises S*. A higher discount rate makes future cash flows less valuable and increases the threshold to commit.
S* as K Varies
Capex → TriggerComparative static: S* is linear in K. Negotiating a 10% price reduction reduces the trigger by exactly 10% — the single highest-leverage lever you control directly.
Reading the Comparative Statics
Why It Matters| Input | Direction | Effect on S* | Why It Matters for Radiology |
|---|---|---|---|
| σ (uncertainty) | ↑ | ↑ | More volatile cash flows raise the option premium. Service lines with new payer rules or unproven volume should require more headroom. |
| δ (cost of waiting) | ↑ | ↓ | Competitor about to open? Existing patient referrals leaking out? Vendor incentive expiring? Higher δ pulls the trigger down — act sooner. |
| r (risk-free rate) | ↑ | ↑ | In high-rate environments the bar is higher. Refresh r at the date of the decision — it can move meaningfully in 12 months. |
| K (capital cost) | ↑ | ↑ (linear) | Every dollar shaved off the purchase price directly reduces the trigger. Vendor negotiation has 1:1 leverage on the decision. |
| Margin per exam | ↑ | No effect on S*; raises S₀ & ρ | Stronger margins make the procedure-built S₀ larger and push ρ toward “Invest.” Validate this carefully against payer mix and contracts. |
| Volume forecast | ↑ | No effect on S*; raises S₀ & ρ | The most commonly overstated input. If you can’t defend it with referral commitments or historical run rate, stress it down 20–30% before deciding. |
From Readiness Ratio to Action
Decision PlaybookA number on a dashboard is not a decision. This tab translates ρ bands into specific actions a radiology leader can take this week. The thresholds reflect standard real-options practice: leave a meaningful margin of safety below the trigger before treating it as a green light.
| Readiness Ratio ρ | Zone | Headline |
|---|---|---|
| ρ < 0.70 | Wait | Expected cash flows don’t justify the option premium. Don’t commit. |
| 0.70 ≤ ρ < 1.00 | Monitor & Negotiate | Close but not there. Use the gap to negotiate or de-risk. |
| ρ ≥ 1.00 | Invest | Bar cleared. Move forward with normal due diligence. |
Action Playbook by Zone
Don’t commit capital today.
The expected PV is well below the trigger. The option to wait is worth more than the option to invest now.
This week:- Document the analysis and present “wait” as an active recommendation, not a passive deferral.
- Identify the single change that would move ρ above 1.0 — price, volume, or contract.
- Set a re-evaluation trigger: a date, a volume threshold, or a payer decision.
- Pilot with mobile or shared-time equipment if applicable.
- Run referring-physician interviews to validate or invalidate the volume forecast.
- Track the largest sensitivity driver from the Sensitivity Lab.
Close, but the gap matters.
You’re in the zone where the deal can be saved by changing the inputs, not by ignoring the model.
Negotiate down K:- Trade-in credits, extended warranty in price, deferred install fees.
- Volume-tied service-contract pricing.
- Demo unit or model-year transition discount.
- Letter of intent from top three referring groups.
- Payer contract clarity on the relevant CPT mix.
- Shared service line agreement with an adjacent facility.
Bar cleared. Move forward.
Expected PV exceeds the trigger. The option premium has been earned.
This week:- Document the analysis in the board memo: K, S₀, S*, ρ.
- Lock vendor pricing and start the financing path (lease vs. purchase analysis).
- Stress-test the recommendation against the top two Sensitivity Lab drivers.
- Define operational KPIs: utilization, time-to-revenue, first-year ramp.
- Plan workflow integration: scheduling, protocols, tech training, MR-safety review.
- Pre-set a 12-month post-go-live review against the Year-1 volume assumption.
Adjusting the Thresholds
The 0.70 / 1.00 thresholds are a starting point, not a regulatory standard. Consider tightening or loosening them by organization context:
| Context | Recommended Adjustment | Rationale |
|---|---|---|
| Critical access / rural hospital with thin cushion | Require ρ ≥ 1.20 to invest | Smaller margin for forecast error; one bad year is more dangerous. |
| Investor-owned or PE-backed outpatient imaging | Lower the wait threshold to ρ ≥ 0.60 | Speed-to-market premium; higher tolerance for volatility. |
| Academic / quaternary referral center | Allow ρ ≥ 0.85 with strategic justification | Capability and reputation effects not captured in the cash-flow model. |
| Replacement of a single-source modality | Treat as ρ ≥ 1.00 if uptime risk is material | Operational continuity carries unmodeled value. |
| Net-new service line with regulatory unknowns | Raise the invest threshold to ρ ≥ 1.30 | Higher cost of being early is wrong. |
How This Fits a Capital Approval Process
- Pre-screen — use this tool early to decide whether to invest analyst time in a full pro forma. If ρ < 0.5 at first pass, document and table the request.
- Capital request memo — include S₀, S*, ρ, and the Sensitivity Lab tornado as a standard exhibit alongside traditional NPV and IRR.
- Board / finance committee — present zone designation (Wait, Monitor, Invest) and the specific actions taken to move ρ into the green band.
- Post-implementation — revisit at 12 and 24 months against the Year-1 volume and margin assumptions used to compute S₀.
The McDonald-Siegel Model in One Page
TheoryThis tool implements the standard real options investment-trigger derivation from McDonald & Siegel (1986), as presented in Dixit & Pindyck’s Investment Under Uncertainty (1994). The decision is framed as a perpetual American call option on a project whose present value follows geometric Brownian motion.
The optimal stopping problem yields a smooth-pasting condition that produces a closed-form trigger. The trigger is always above the capital cost K, and the gap shrinks as uncertainty σ falls or the cost of waiting δ rises.
The Three Equations
½ ⋅ σ² ⋅ β(β − 1) + (r − δ) ⋅ β − r = 0Take the positive root > 1.
S* = ( β / (β − 1) ) ⋅ K
ρ = S₀ / S*
S₀ = Σt=1..H [ (Σj Vj,t ⋅ mj) − Opex ] / (1 + r)twhere Vj,t = Vj,0 ⋅ (1 + gj)t−1
What Each Symbol Means
Reference| Symbol | Meaning | Typical Range (Imaging) |
|---|---|---|
| K | Capital cost — equipment, install, siting, validation | $500K – $5M |
| r | Risk-free rate (10-yr Treasury) | 0.030 – 0.055 |
| σ | Annualized volatility of project PV | 0.20 – 0.45 |
| δ | Cost of waiting / dividend yield on the project | 0.04 – 0.12 |
| T | Decision window (years) | 0.5 – 3 |
| H | PV horizon = equipment useful life | 5 – 12 |
| Vj,t | Volume of procedure j in year t | varies |
| mj | Margin per exam for procedure j | $150 – $750 |
| gj | Annual growth rate of procedure j | −0.03 – 0.08 |
| Opex | Annual incremental operating cost | $150K – $600K |
| β | Investment elasticity (model output, > 1) | 1.5 – 3.0 |
| S* | Investment trigger (model output) | 1.3 – 2.5 × K |
| ρ | Readiness ratio S₀ / S* (model output) | — |
Solving the Quadratic for β
ComputationThe fundamental quadratic rewrites as:
(½σ²) ⋅ β² + (r − δ − ½σ²) ⋅ β − r = 0
With a = ½σ², b = r − δ − ½σ², c = −r:
β = ( −b + √(b² − 4ac) ) / (2a)
This is the positive root that satisfies β > 1. The discriminant b² − 4ac is always positive in the economically meaningful region, so the root is real.
Comparative Statics (Why the Model Behaves the Way It Does)
Intuition| Parameter Change | Effect on β | Effect on S* | Intuition |
|---|---|---|---|
| σ ↑ | ↓ | ↑ | More uncertainty raises the value of waiting, which raises the required trigger. |
| δ ↑ | ↑ | ↓ | Waiting becomes more expensive; you invest sooner. |
| r ↑ | varies | ↑ typically | Higher discount rate lowers PV of cash flows; threshold rises. |
| K ↑ | no change | ↑ (linear) | S* scales 1:1 with K. β depends only on r, σ, δ. |
Assumptions & Limitations
Be CarefulThe closed-form trigger is convenient but rests on assumptions that should be checked before treating the output as definitive.
- Geometric Brownian motion for S. PV is assumed to evolve smoothly with constant volatility σ. Real radiology cash flows can jump (payer policy change, competitor entry, regulatory event). For known discrete-event risks, augment with scenario analysis.
- Perpetual option. The closed form assumes you can wait forever. Set a finite decision window T using business logic (vendor pricing expiry, equipment end-of-life, certificate-of-need deadline). If T is short relative to the volatility, the trigger should be interpreted as a lower bound on the true threshold.
- Constant parameters. r, σ, and δ are held constant. In practice all three drift. Refresh inputs at the date of the decision; don’t rely on a model run from 12 months ago.
- Single decision. The model treats the purchase as a one-shot commitment. If the real decision is staged (buy a refurbished unit now, replace in 3 years), model it as a compound option or in stages.
- Volatility is the hardest input to estimate. Common approaches: (a) coefficient of variation of historical service-line contribution margin over 3–5 years; (b) implied volatility from comparable public-company segment results; (c) expert elicitation with a triangular distribution and a parametric fit. State your method.
- No taxes, no inflation, no operating leverage. The framework is pre-tax and treats margin per exam as constant in real terms. For heavily-leveraged organizations or material tax positions, run a parallel after-tax DCF before deciding.
- Strategic value not captured. Reputation, recruiting, teaching mission, payer-mix steering, and downstream service-line effects don’t appear in the model. They can justify investing below ρ = 1.0 in specific contexts, but should be argued explicitly — not assumed implicitly.
References
Source Material- McDonald, R. & Siegel, D. (1986). The value of waiting to invest. Quarterly Journal of Economics, 101(4), 707–727.
- Dixit, A. & Pindyck, R. (1994). Investment Under Uncertainty. Princeton University Press. Chapters 5–6.
- Trigeorgis, L. (1996). Real Options: Managerial Flexibility and Strategy in Resource Allocation. MIT Press.
- Copeland, T. & Antikarov, V. (2003). Real Options: A Practitioner’s Guide. Texere.
- Brennan, M. & Schwartz, E. (1985). Evaluating natural resource investments. Journal of Business, 58(2), 135–157.
- Emrick, K. (2024). Fiscal Fitness: Strengthening Hospital Financial Performance. Ch. on capital decisions under uncertainty.
Pair This Tool With…
Companion DashboardsThis analyzer answers one specific question: given my best estimates, should I invest in this equipment now? A full capital decision benefits from companion tools that pressure-test the inputs, model the downstream operations, and frame the strategic context.
Inputs — Pressure-Test Your Numbers
Healthcare Probabilistic Modeling
Translate point-estimate inputs into distributions. Use the outputs to set a defensible σ for this analyzer.
Monte-Carlo Simulations
Run thousands of trials of the procedure-built S₀ to see the full distribution of ρ, not just the point value.
Outcome Uncertainty Modeling
Frameworks for quantifying parameter uncertainty — especially useful for σ and growth-rate assumptions.
Hospital Financial Benchmarks
Calibrate r, opex, and margin assumptions against industry benchmarks before running this analyzer.
Imaging-Specific — Strategy & Operations Context
MRI Service-Line Expansion Tool
If this analyzer is recommending invest, use this companion tool to plan the operational ramp.
Imaging Services Analysis
Service-line analytics for understanding the volume and margin profile that drives S₀.
Radiology Operations Dashboard
Operational KPIs for the post-investment monitoring plan.
Radiology KPIs
Define the operational metrics you’ll track in year 1 to validate the volume and margin assumptions.
MRI Command Center Dashboard
Operational visibility into utilization, throughput, and capacity post-go-live.
MRI Safety Dashboard
ACR safety governance and zone compliance for the installation phase.
Financial & Strategic Frame
Healthcare Financial Projection Dashboard
Multi-year pro forma to compare this analyzer’s recommendation against a full DCF.
Financial Outcome Predictor (Healthcare)
Predictive view of how this capital decision flows through to organizational financials.
Healthcare Finance KPIs
Reference for the organizational financial KPIs that frame this decision (debt service, days cash, EBITDA).
Patient Leakage Recovery Simulator
Quantify the cost-of-waiting δ from imaging volume leaking to competitors.
Decision & Leadership
Leadership Under Pressure
For the hardest decisions — the ρ = 0.85 cases where the model says monitor and the politics say move.
Game Theory & Leadership
Frame the cost of waiting δ rigorously when a competitor’s move is the dominant risk.
Theory of Constraints
Useful when the question is whether new imaging capacity is the actual bottleneck.
Two-Step Company Evaluation
Adjacent framework for evaluating the strategic context around the capital decision.